20/20 HealthCare Partners
  • Home
  • What Differentiates 20/20 HCP
  • Team
  • Companies
    • Companies
    • Exits
  • News
  • Contact

20/20 HealthCare Partners

12 Oct2015

Corindus Vascular Robotics and Mayo Clinic Launch Vascular Robotic Program to Research Physician Safety

Written by 2020HCP.com. Posted in News

WALTHAM, MA – October 12, 2015 – Corindus Vascular Robotics [NYSE MKT: CVRS] today announced the formation of a joint robotic-assisted percutaneous coronary intervention (PCI) research and clinical program. The program utilizes the company’s CorPath® System, the first and only FDA-cleared medical device to provide robotic-assisted precision to coronary PCI procedures while protecting hospital employees from occupational radiation exposure and orthopedic stress and strain.
  • Continue Reading
01 Oct2015

Konica Minolta Acquires Viztek to Enhance Healthcare IT Solution Capabilities

Written by 2020HCP.com. Posted in News, Uncategorized

Wayne, NJ, October 1, 2015 – Konica Minolta, Inc. today announced the completed acquisition of Garner, North Carolina based Viztek, LLC, a leading innovative healthcare company, through Konica Minolta Medical Imaging. With this acquisition, Konica Minolta enhances its capabilities to offer comprehensive, end-to-end healthcare IT solutions from image acquisition to physician diagnosis. It also adds to the established strength
  • Continue Reading
01 Jun2015

UltraSPECT to Present Xpress Suite of Safer Imaging Solutions at SNMMI 2015

Written by 2020HCP.com. Posted in News

 SNMMI Attendees Invited to Take Part in New “Hot Trot 5K” Run/Walk to Benefit Professional Development of Nuclear Medicine Technologists Auburndale, Mass., June 1, 2015 (SNMMI Booth #517) – UltraSPECT, a provider of the most cost-effective and vendor-neutral low dose and ultra-low-dose nuclear medicine imaging solutions, will present its Xpress suite of value packages at booth #517 during the Society of Nuclear Medicine & Molecular Imaging (SNMMI) annual meeting from June 6-10 in Baltimore, MD. Low dose imaging increases safety for patients and technologists while providing physicians with high-quality images for accurate diagnosis.
  • Continue Reading
28 May2014

20/20 HealthCare Partners Collaborates with Roche to Source and Advance BioTech Innovations

Written by 2020HCP.com. Posted in News

May 28, 2014 – Auburndale, Mass. – 20/20 HealthCare Partners LLC (20/20 HCP), a global investment group focused on early stage medical technology and life science innovation, is pleased to announce an agreement with Roche, in which they will source and identify novel treatments and/or technologies in the biotech arena. These areas include oncology/immuno-oncology, neurology, infectious diseases, inflammation and ophthalmology. The partnership aims to advance any identified technologies by facilitating collaborations or the formation of new life science companies.
  • Continue Reading
19 Mar2008

INVESTMENT IN CORINDUS, INC.

Written by 2020HCP.com. Posted in News

March 19, 2008 — 20/20 HealthCare Partners LLC (Auburndale, MA) is pleased to announce that its portfolio company, Corindus, Inc., closed a B Round investment taken solely by a New York based hedge fund / private equity fund specializing in the health care industry. Corindus will use the financing to enhance its management structure, complete product development and obtain regulatory approvals in the US and Europe.

The initial funding round led by 20/20 HealthCare Partners in September 2005 enabled Corindus to progress from an early stage company through development of a sophisticated, fully functional robotic catheterization system for the CathLab.

  • Continue Reading
  • 1
  • ...
  • 10
  • 11
  • 12
  • 13

Latest News

  • Variantyx Secures $20M Debt Financing to Support Precision Medicine in North America, Europe October 18, 2022
  • SQZ Biotechnologies Presents Celiac Disease Tolerizing Antigen Carrier Preclinical Data at 2022 Federation of Clinical Immunology Societies (FOCIS) Annual Meeting June 21, 2022
  • SQZ Biotechnologies Receives FDA Fast Track Designation for its Lead Cell Therapy Candidate for the Treatment of HPV16+ Tumors April 28, 2022
  • SQZ Biotechnologies Presents New eAPC Preclinical Data Demonstrating That Multiplexed mRNA Engineering of Immune Cells Increases Killer T Cell Activity In Vivo April 11, 2022
  • SQZ Biotechnologies Publishes Comprehensive Preclinical Research on SQZ® TAC Platform’s Ability to Induce Multiple Key Mechanisms of Antigen-Specific Tolerance and Protect Against Type 1 Diabetes April 5, 2022

20/20 HealthCare Partners | 2000 Commonwealth Ave, Suite 200, Auburndale, MA 02466 | Contact Us

Copyright © 2019
  • Home
  • What Differentiates 20/20 HCP
  • Team
  • Companies
    • Companies
    • Exits
  • News
  • Contact